Previously, Nutrition Insight spoke with AceBiomes CEO, Myeong Hee Kim, about its clinically proven core probiotic, Lactobacillus gasseri BNR17, which specifically targets visceral fat and is the first probiotic approved by the Korean Ministry of Food and Drug Safety for body fat reduction
By examining these trends, the study sheds light on how the field of weight loss treatment is evolving
Bu yollar, cAMP'ye bal sistemlerin yan sra, farkl metabolik talepler nda glukagon dearjn byk lde kalibre eden PKA ve PI3K gibi hcre ii iaretleyici paracklarla ibirliini de kapsar
Along with weight, clinicians often recommend tracking appetite, portion sizes, and how full you feel after meals
Retatrutide led to dose-dependent reductions in body weight of up to 24.2% at 48 weeks, with a safety profile comparable to other GLP-1-based therapies. Jastreboff et al., NEJM Secondary Benefits Improved HbA1c in both diabetic and pre-diabetic participants Significant reductions in liver fat (a marker for NAFLD/NASH reversal) Lowered triglycerides, LDL, and inflammatory markers Favorable impact on blood pressure and fasting insulin levels Tolerability and Safety Most side effects were GI-related and dose-dependent : Nausea Constipation Occasional vomiting All were similar in frequency and severity to those seen in Semaglutide trials No serious adverse events were reported Dropout rates were low across all dose groups These results suggest Retatrutide may offer not only more dramatic weight loss , but also better metabolic improvements and potential muscle-sparing advantages making it a standout candidate for both medical and performance-focused applications
